 Castration nilutamide vs castration placebo advanced prostate cancer review Combination antiandrogen treatment surgical medical castration efficacy endocrine treatment prostatic cancer effects adrenal androgens nonsteroidal antiandrogen promising results preliminary open studies short-term days comparison nilutamide buserelin buserelin placebo mg/day bone pain patients pain control group initial buserelin-induced increase prostatic acid phosphatase nilutamide similar increase testosterone gonadotropin concentrations control group tumor flare-up start hormone-releasing hormone LH-RH treatment endocrine responses multicenter double-blind placebo-controlled trials castration patients combination nilutamide castration bone pain performance status number patients objective regression patients Nilutamide visual disorders gastrointestinal disorders alcohol intolerance patients results nilutamide efficacy castration patients prostatic cancer Current studies effects treatment survival risk-benefit ratio